Acousia Therapeutics completes patient enrolment in Phase 2 trial of Bimokalner

ZYUS Life Sciences reports positive preliminary results from Phase 2a trial of Trichomylin softgel

Antin to acquire clinical trial equipment provider Emsere

Foresee licenses global rights to MMP-12 inhibitor programmes to Primevera

Arbele's ARB1002 receives US FDA Orphan Drug Designation

Sobi reports topline results from Phase 2a EMBRACE study of Gamifant for interferon-gamma-driven sepsis

Compass Pathways wins FDA IND acceptance for COMP360 PTSD trial

Merck completes acquisition of Cidara Therapeutics for USD9.2bn

HUTCHMED reports positive Phase III results for sovleplenib in wAIHA

GSK reports positive phase III results for bepirovirsen in chronic hepatitis B

Bambusa Therapeutics reports first patient dosed in proof-of-concept COPD trial

Legacy Healthcare's Cinainu gains US FDA approval to advance multi-regional Phase 3 trial in alopecia areata

Health Canada approves AbbVie's eight-week MAVIRET regimen for acute and chronic hepatitis C

Cartography Biosciences partners with Pfizer to discover tumour-selective antigens

Nimbus Therapeutics partners with Lilly to develop oral obesity treatment